Dr Atallah is the Associate Dean for Clinical Affairs at Dubai Medical University. Prior to joining DMU he served as Cardiovascular Senior Pharmacotherapy Specialist at Cleveland Clinic Abu Dhabi and Clinical Associate Professor at Cleveland Clinic Lerner College of Medicine. Prior to joining Cleveland Clinic he was on faculty as Assistant Professor of Clinical Pharmacy at King Saud bin Abdulaziz University for Health Sciences (KSAU-HS) in Riyadh. Dr. Atallah received his PharmD from Bernard J. Dunn School of Pharmacy in Virginia and completed an ASHP accredited post graduate residency at Winchester Medical Center in Virginia. He was awarded the “Graduate of the Last Decade” award by his alma mater. Dr. Atallah is board certified in pharmacotherapy with added qualifications in Cardiology. He also holds an advanced antithrombotic management certificate from ASHP. Dr Atallah is a fellow of the Heart Failure Society of America (HFSA) and the American College of Clinical Pharmacy (ACCP). He has several publications and presentations at national and international conferences. He was awarded the 2021 ACCP Cardiology PRN international award. His research interests are in various aspects of cardiovascular pharmacotherapy with focus on antithrombotic therapy, heart failure and hyperlipidemia.

Mosa’b Al-Balas is an internationally accredited clinical pharmacist and healthcare leader with extensive experience across Canada and the UAE. Holding a Doctor of Pharmacy (PharmD) degree from the University of Toronto, along with an MBA, he is recognized for his expertise in clinical pharmacy, regulatory compliance, medical education, and patient-centered pharmaceutical care. He has contributed to residency training, clinical research, and multidisciplinary healthcare initiatives while advancing excellence in pharmacy practice and professional development.